Pharma & Biotech

Investors showed renewed confidence in Capricor Therapeutics last week following a significant regulatory development from the U.S. Food and Drug...

A recent analyst report dated September 29 has cast a favorable light on Aldeyra Therapeutics, identifying the biotechnology company as...

The biotechnology leader Amgen presents investors with a puzzling scenario. Despite announcing substantial capital investments and reporting robust quarterly earnings,...

The animal health sector leader Zoetis finds itself navigating turbulent market conditions, presenting investors with a perplexing scenario. While the...

Investors in Cellectar Biosciences are bracing for significant volatility as the company approaches two major developments that could dramatically influence...

The equity performance of Gilead Sciences has captured significant market attention, with its shares advancing more than 25% since the...

Sarepta Therapeutics shares advanced 3.6% to $18.72 in the latest trading session, yet this modest gain conceals a deeply fractured...

The leadership team at Redcare Pharmacy is undergoing a significant transition as the company's long-serving Chief Financial Officer announces his...

The telehealth sector, known for its rapid digital innovation, is facing increased regulatory scrutiny. Hims & Hers Health, Inc., a...

Pharmaceutical giant Bristol-Myers Squibb is navigating turbulent waters as it implements an unconventional approach to maintain its market position. With...